Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-29

Clinical Trial Update: A Clinical Trial Evaluating Efficacy and Safety of MC2-01 Cream [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of MC2-01 Cream for psoriasis has completed, with results posted in October 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MC2-01 Cream

Snippet

Sponsor: MC2 Therapeutics | Conditions: Psoriasis Vulgaris | Phase 3 | Status: COMPLETED | Results posted: 2019-10-29